NAPLES, Fla., June 19, 2019 / PRNewswire / – Half a million dollars in Alzheimer's disease (AD) research grants recently announced by the Infectious Diseases Society of America Foundation and the possibly millions of dollars of "high priority" donations offered by the National Institute on Aging to study of infectious agents in AD, are a "welcome affirmation" of the need to investigate in more detail the possible roles of germs in triggering AD, says Leslie Norins, MD, PhD, CEO of Alzheimer's Germ Quest, Inc.
"This new funding from these two authorities will help alleviate a serious shortage of research grants to accompany many promising clues that viruses, bacteria and other pathogens are involved in AD," says Dr. Norins. It urges scientists with microbiological talents to apply.
Strangely, he says, several AD advocacy groups still seem to be ignoring microbes, and continue to channel their research funds almost exclusively to the traditional topics of amyloid plaques and tau tangles. Dr. Norins attributes this to a lack of infectious disease specialists in his policies and provides review committees.
Dr. Norins also points to a recent article in ALZFORUM, which reported that an anti-viral drug given to fight hepatitis C may also reduce the late development of Parkinson's disease. It read: "[This] supports emerging evidence that infections contribute to neurodegeneration. "Dr. Norins recalls that" AD, like Parkinson's, is an important neurodegenerative disease. "
Alzheimer's Germ Quest is a public utility company based in Naples. Florida It is self-funded and does not solicit or accept external donations. Its mission is to accelerate and deepen the research on the possibility of a microbiological agent triggering AD. It is the sponsor of the US $ 1 million Challenge Award for the scientist who proves that an infectious organism is the cause of AD. Recently, it launched a US $ 100,000 hunt the world's first proven case of spontaneous healing.
SOURCE Alzheimer's Germ Quest, Inc.